Akari Therapeutics Issues 2025 End of Year Letter to Shareholders

TAMPA, Fla. and LONDON, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology ...

Akari Therapeutics Plc: Akari Therapeutics Issues 2025 End of Year Letter to Shareholders

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads today ...
Water Technology

A new era of semiconductor water management: Challenges, constraints and cutting-edge solutions

As chip manufacturing scales up, water supply and wastewater treatment systems are under immense pressure. Cutting-edge ...
eLife

Prolonged oscillating kisspeptin neuron activity underlies the preovulatory luteinizing ...

This important work advances our understanding of the role of kisspeptin neurons in regulating the luteinizing hormone (LH) surge in females. The evidence demonstrating increased neuronal activity in ...